Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
JNJ-42226314 is an inhibitor of monoacylglycerol lipase (MAGL; IC50 = 10 nM).1 It is selective for MAGL over a panel of 15 serine proteases at 10 µM. JNJ-42226314 (30 mg/kg) increases the latency to paw withdrawal in the hot plate test and the brain levels of 2-arachidonoyl glycerol (2-AG; Item No. 62160) in rats. It increases the latency to fall asleep and the development of non-rapid eye movement (NREM) and REM sleep, as well as increases the cortical levels of norepinephrine, in rats when administered at a dose of 30 mg/kg.2 Radiolabeled forms of JNJ-42226314 have been used for autoradiography and PET tracers for MAGL in the brains of rats and rhesus monkeys.3
WARNING This product is not for human or veterinary use.
1. The discovery of azetidine-
2. Pharmacologic characterization of JNJ-
3. Novel reversible-